SaNOtize is a biotech company using a platform technology for topical treatment to address upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug-resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others. SaNOtize was founded in 2017 by Gilly Regev and Chris Miller, and it is headquartered in Vancouver, British Columbia.